跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Optavir - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Optavir
Approved
STANDARD
Optavir
Remington Pharmaceutical (Pvt.) Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
73cd0e14c02e0557
Company
Remington Pharmaceutical (Pvt.) Ltd.
Type
Standard
Approval Details
Approval Id
73cd0e14c02e0557
Drug Approval Philippines Name
Optavir
Product Name
Optavir
Registration Number
DR-XY43358
Brand Name
Optavir
Generic Name
AcicIovir
Dosage Form
Ophthalmic Ointment
Dosage Strength
30mg/g (3% w/w)
Manufacturer
Remington Pharmaceutical (Pvt.) Ltd.
Importer
Ophthamed Pharma Corp.
Distributor
Ophthamed Pharma Corp.
Issuance Date
29 March 2024
Expiry Date
16 April 2029
Pharmacologic Category
Antiviral
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
73cd0e14c02e0557
Type
Standard
Back to Philippines FDA Approvals